An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
Michael Proctor(University of Florida), Donald C. McMillan(Glasgow Royal Infirmary)
Cited by 526
Related Papers
Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer
|Annals of Surgery|2019|298
An integrated platform of genomic assays reveals small-molecule bioactivities
|Nature Chemical Biology|2008|207
Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer
|Clinical Nutrition|2019|144
The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer
|British Journal of Cancer|2013|134
Prognostic role of preoperative circulating systemic inflammatory response markers in primary breast cancer: meta-analysis
|British journal of surgery|2022|77